BXP, Inc. (NYSE: BXP) is a Real Estate company in the REIT - Office industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
67.38
-2.33-3.34%
TA
Loading chart...
Snapshot
| Index | S&P 500 | P/E | 37.28 | EPS (ttm) | 1.87 | Insider Own | 2.23% | Shs Outstand | 159.48M | Perf Week | -0.58% |
| Market Cap | 11.12B | Forward P/E | 39.50 | EPS next Y | 1.76 | Insider Trans | -1.12% | Shs Float | 147.87M | Perf Month | 4.15% |
| Enterprise Value | 26.92B | PEG | - | EPS next Q | 0.49 | Inst Own | - | Short Float | 7.46% | Perf Quarter | 17.24% |
| Income | 297.94M | P/S | 3.16 | EPS this Y | 10.15% | Inst Trans | - | Short Ratio | 7.10 | Perf Half Y | 10.35% |
| Sales | 3.52B | P/B | 2.15 | EPS next Y | -13.87% | ROA | 1.18% | Short Interest | 11.03M | Perf YTD | 3.30% |
| Book/sh | - | P/C | 14.93 | EPS next 5Y | - | ROE | 5.80% | 52W High | 76.68 -12.13% | Perf Year | 5.59% |
| Cash/sh | - | P/FCF | 24.37 | EPS past 3/5Y | -31.44% -20.68% | ROIC | 4.89% | 52W Low | 48.06 40.21% | Perf 3Y | 3.98% |
| Dividend Est. | 2.80 (4.16%) | EV/EBITDA | 14.44 | Sales past 3/5Y | 3.85% 4.71% | Gross Margin | 46.81% | Volatility | 2.28% 2.77% | Perf 5Y | -40.61% |
| Dividend TTM | 2.80 (4.16%) | EV/Sales | 7.66 | EPS Y/Y TTM | 1966.67% | Oper. Margin | 35.01% | ATR (14) | 1.95 | Perf 10Y | -50.01% |
| Dividend Ex-Date | Jun 30, 2026 | Quick Ratio | 0.94 | Sales Y/Y TTM | 3.20% | Profit Margin | 8.44% | RSI (14) | 53.94 | Recom | 2.44 |
| Dividend Gr. 3/5Y | -5.01% -3.04% | Current Ratio | 0.94 | EPS Q/Q | -74.85% | SMA20 | 0.42% | Beta | 1.01 | Target Price | 71.40 |
| Payout | 183.51% | Debt/Eq | 3.17 | Sales Q/Q | 3.23% | SMA50 | 4.38% | Rel Volume | 0.62 | Prev Close | 69.71 |
| Employees | 826 | LT Debt/Eq | 2.16 | Earnings | Oct 27 | SMA200 | 9.09% | Avg Volume | 1.46M | Price | 67.38 |
| IPO Date | Jun 18, 1997 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 6.68% 4.38% | Net Debt/EBITDA | 8.47 | Volume | 909,393 | Change | -3.34% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-05-26 | Reiterated | UBS | Neutral | $74 → $76 |
| Jul-21-26 | Reiterated | Scotiabank | Sector Outperform | $70 → $74 |
| Jul-21-26 | Reiterated | Barclays | Overweight | $65 → $79 |
| Jul-21-26 | Reiterated | Piper Sandler | Overweight | $85 → $86 |
| Jul-21-26 | Reiterated | Mizuho | Neutral | $62 → $68 |
| Jul-06-26 | Reiterated | Evercore ISI Group | In Line | $62 → $68 |
| Jun-18-26 | Upgrade | Scotiabank | Sector Perform → Sector Outperform | $77 → $70 |
| Jun-02-26 | Reiterated | BMO Capital | Outperform | $84 → $68 |
| May-18-26 | Reiterated | Barclays | Overweight | $81 → $65 |
| May-15-26 | Reiterated | Cantor Fitzgerald | Overweight | $79 → $70 |
Latest News
Today
Aug-05-26
Aug-04-26
04:17AM
03:44AM
Jul-30-26
Jul-30-2603:37AM
Jul-29-26
03:33PM
BXP, Inc. (BXP) Q2 2026 Earnings Call Transcriptseekingalpha.com
Jul-28-26
06:26PM
BXP: Solid Q2, But Long-Term Debt Concerns Limit Upsideseekingalpha.com
06:20PM
04:14PM
04:09PM
BXP Announces Second Quarter 2026 Resultsbusinesswire.com
Jul-24-26
Jul-24-2606:15PM
Company
BXP, trading on the NYSE, is the leading publicly listed company engaged in the development and ownership of premier Class A office properties across the United States. Its operations are strategically concentrated in five major urban centers: Boston, Los Angeles, New York, San Francisco, and Washington, D.C. Structured as a Real Estate Investment Trust (REIT), the company operates as a comprehensive real estate entity, involved in the full spectrum of activities from developing and acquiring to managing and operating a diverse collection of primarily Class A office assets. Its current property holdings consist of 196 assets, collectively spanning 51.2 million square feet, which includes six properties actively undergoing construction or significant redevelopment.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,517 | 3,482 | 3,408 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,870 | 1,373 | 1,322 | — | — | — | — | — | — | |
| Gross Profit | 1,645 | 2,109 | 2,086 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 137 | 169 | 176 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 277 | 0 | 888 | — | — | — | — | — | — | |
| Operating Income | 1,231 | 1,940 | 1,022 | — | — | — | — | — | — | |
| Interest Expense | 619 | 648 | 645 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -198 | -908 | -293 | — | — | — | — | — | — | |
| Net Income Before Taxes | 413 | 384 | 84 | — | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | — | — | — | — | — | — | |
| Consolidated Net Income | 297 | 277 | 14 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 413 | 384 | 84 | — | — | — | — | — | — | |
| Net Income | 297 | 277 | 14 | — | — | — | — | — | — | |
| EPS (Recurring) | 1.87 | 1.75 | 0.09 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 1.87 | 1.75 | 0.09 | — | — | — | — | — | — | |
| EPS (Diluted) | 1.86 | 1.74 | 0.09 | — | — | — | — | — | — | |
| EBITDA | 1,865 | 1,938 | 1,619 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 36.23 | 38.78 | 826.22 | — | — | — | — | — | — | |
| Price To Sales Ratio | 3.05 | 3.08 | 3.43 | — | — | — | — | — | — | |
| Gross Margin | 46.77 | 60.57 | 61.21 | — | — | — | — | — | — | |
| Operating Margin | 35.00 | 55.72 | 29.99 | — | — | — | — | — | — | |
| Net Margin | 8.44 | 7.96 | 0.41 | — | — | — | — | — | — | |
| Shares Outstanding | 159 | 159 | 157 | — | — | — | — | — | — | |
| Market Capitalization | 10,713 | 10,729 | 11,675 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| LABELLE MICHAEL E | EVP and CFO | Jun 09 '26 | Sale | 66.35 | 26,113 | 1,732,533 | 5,839 | Jun 10 |
| Kevorkian Eric G | SVP, CLO and Secretary | May 22 '26 | Sale | 59.85 | 2,000 | 119,702 | 311 | May 26 |
| Kevorkian Eric G | SVP, CLO and Secretary | May 21 '26 | Sale | 60.23 | 200 | 12,045 | 2,311 | May 26 |
| Otteni Peter V | Executive Vice President | May 20 '26 | Sale | 59.06 | 4,863 | 287,186 | 0 | May 20 |
| Spann Hilary J. | Executive Vice President | Feb 27 '26 | Sale | 59.69 | 5,495 | 327,997 | 17,832 | Mar 02 |
| THOMAS OWEN D | Chief Executive Officer | Feb 13 '26 | Sale | 61.22 | 1,198 | 73,341 | 0 | Feb 13 |
| Spann Hilary J. | Executive Vice President | Feb 05 '26 | Sale | 63.31 | 1,194 | 75,592 | 17,832 | Feb 06 |
| RITCHEY RAYMOND A | Senior EVP | Dec 01 '25 | Sale | 72.18 | 36,314 | 2,621,134 | 0 | Dec 02 |
| Otteni Peter V | Executive Vice President | Nov 25 '25 | Sale | 72.65 | 4,136 | 300,470 | 0 | Nov 25 |
| Stroman John J | Executive Vice President | Nov 12 '25 | Sale | 72.17 | 16,838 | 1,215,239 | 0 | Nov 12 |
| LABELLE MICHAEL E | EVP and CFO | Nov 07 '25 | Sale | 72.34 | 13,422 | 970,952 | 9,223 | Nov 10 |
| Garesche Donna D | EVP, Chief HR Officer | Mar 05 '25 | Sale | 67.87 | 2,143 | 145,453 | 0 | Mar 07 |
| Spann Hilary J. | Executive Vice President | Feb 04 '25 | Sale | 72.02 | 12,379 | 891,536 | 7,271 | Feb 05 |
| RITCHEY RAYMOND A | Senior EVP | Sep 09 '24 | Sale | 74.25 | 21,835 | 1,621,225 | 0 | Sep 10 |
| Otteni Peter V | Executive Vice President | Aug 23 '24 | Sale | 73.44 | 4,785 | 351,421 | 0 | Aug 26 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.